DOCSLIB.ORG

Cognitive Behavioural & Relapse Prevention Strategies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

LeaderLeader’’ss GuideGuide CognitiveCognitive BehaviouralBehavioural && RelapseRelapse PreventionPrevention StrategiesStrategies Treatnet Training Volume B, Module 3: Updated 18 September 2007 1 TrainingTraining goalsgoals 1. IncreaseIncrease knowledgeknowledge ofof cognitivecognitive behaviouralbehavioural therapytherapy (CBT)(CBT) andand relapserelapse preventionprevention (RP)(RP) strategiesstrategies andand resources.resources. 2. IncreaseIncrease skillsskills usingusing CBTCBT andand RPRP strategiesstrategies andand resources.resources. 3. IncreaseIncrease applicationapplication ofof CBTCBT andand RPRP strategiesstrategies forfor substancesubstance abuseabuse treatmenttreatment 2 ModuleModule 3:3: WorkshopsWorkshops WorkshopWorkshop 1:1: BasicBasic ConceptsConcepts ofof CBTCBT andand RPRP WorkshopWorkshop 2:2: CognitiveCognitive BehaviouralBehavioural StrategiesStrategies WorkshopWorkshop 3:3: MethodsMethods forfor UsingUsing CognitiveCognitive BehaviouralBehavioural StrategiesStrategies 3 WorkshopWorkshop 1:1: BasicBasic ConceptsConcepts ofof CBTCBT andand RPRP 4 PrePre--assessmentassessment 10 Min. PleasePlease respondrespond toto thethe prepre--assessmentassessment questionsquestions inin youryour workbook.workbook. (Your(Your responsesresponses areare strictlystrictly confidential.)confidential.) 5 IcebreakerIcebreaker IfIf youyou hadhad toto movemove toto anan uninhabiteduninhabited island,island, whatwhat 33 thingsthings wouldwould youyou taketake withwith youyou andand why?why? (food(food andand waterwater areare provided)provided) 6 TrainingTraining objectivesobjectives At the end of this workshop, you will: 1. Understand that substance use is a learned behaviour that can be modified according to principles of conditioning and learning 2. Understand key principles of classical and operant conditioning and modelling 3. Understand how these principles apply to the treatments delivered in cognitive behavioural therapy and relapse prevention training 4. Understand the basic approaches used in cognitive behavioural therapy and how they apply to reducing drug use and preventing relapse 5. Understand how to conduct a functional analysis and know about the 5 Ws of a client’s drug use 7 WhatWhat areare CognitiveCognitive BehaviouralBehavioural TherapyTherapy (CBT)(CBT) andand RelapseRelapse PreventionPrevention (RP)?(RP)? 8 WhatWhat isis CBTCBT andand howhow isis itit usedused inin addictionaddiction treatment?treatment? ¾ CBTCBT isis aa formform ofof ““talktalk therapytherapy”” thatthat isis usedused toto teach,teach, encourage,encourage, andand supportsupport individualsindividuals aboutabout howhow toto reducereduce // stopstop theirtheir harmfulharmful drugdrug use.use. ¾ CBTCBT providesprovides skillsskills thatthat areare valuablevaluable inin assistingassisting peoplepeople inin gaininggaining initialinitial abstinenceabstinence fromfrom drugsdrugs (or(or inin reducingreducing theirtheir drugdrug use).use). ¾ CBTCBT alsoalso providesprovides skillsskills toto helphelp peoplepeople sustainsustain abstinenceabstinence (relapse(relapse prevention)prevention) 9 WhatWhat isis relapserelapse preventionprevention (RP)?(RP)? BroadlyBroadly conceived,conceived, RPRP isis aa cognitivecognitive--behaviouralbehavioural treatmenttreatment (CBT)(CBT) withwith aa focusfocus onon thethe maintenancemaintenance stagestage ofof addictiveaddictive behaviourbehaviour changechange thatthat hashas twotwo mainmain goals:goals: ToTo preventprevent thethe occurrenceoccurrence ofof initialinitial lapseslapses afterafter aa commitmentcommitment toto changechange hashas beenbeen mademade andand ToTo preventprevent anyany lapselapse thatthat doesdoes occuroccur fromfrom escalatingescalating intointo aa fullfull--blowblow relapserelapse BecauseBecause ofof thethe commoncommon elementselements ofof RPRP andand CBT,CBT, wewe willwill referrefer toto allall ofof thethe materimaterialal inin thisthis trainingtraining modulemodule asas CBTCBT 10 FoundationFoundation ofof CBT:CBT: SocialSocial LearningLearning TheoryTheory CognitiveCognitive behaviouralbehavioural therapytherapy (CBT)(CBT) ¾¾ProvidesProvides criticalcritical conceptsconcepts ofof addictionaddiction andand howhow toto notnot useuse drugsdrugs ¾¾EmphasisesEmphasises thethe developmentdevelopment ofof newnew skillsskills ¾¾InvolvesInvolves thethe masterymastery ofof skillsskills throughthrough practisepractise 11 WhyWhy isis CBTCBT useful?useful? (1)(1) ¾ CBTCBT isis aa counselingcounseling--teachingteaching approachapproach wellwell--suitedsuited toto thethe resourceresource capabilitiescapabilities ofof mostmost clinicalclinical programsprograms ¾ CBTCBT hashas beenbeen extensivelyextensively evaluatedevaluated inin rigorousrigorous clinicalclinical trialstrials andand hashas solidsolid empiricalempirical supportsupport ¾ CBTCBT isis structured,structured, goalgoal--oriented,oriented, andand focusedfocused onon thethe immediateimmediate problemsproblems facedfaced byby substancesubstance abusersabusers enteringentering treatmenttreatment whowho areare strugglingstruggling toto controlcontrol theirtheir useuse 12 WhyWhy isis CBTCBT useful?useful? (2)(2) ¾ CBTCBT isis aa flexible,flexible, individualizedindividualized approachapproach thatthat cancan bebe adaptedadapted toto aa widewide rangerange ofof clientsclients asas wellwell asas aa varietyvariety ofof settingssettings (inpatient,(inpatient, outpatient)outpatient) andand formatsformats (group,(group, individual)individual) ¾ CBTCBT isis compatiblecompatible withwith aa rangerange ofof otherother treatmentstreatments thethe clientclient maymay receive,receive, suchsuch asas pharmacotherapypharmacotherapy 13 ImportantImportant conceptsconcepts inin CBTCBT (1)(1) InIn thethe earlyearly stagesstages ofof CBTCBT treatment,treatment, strategiesstrategies stressstress behaviouralbehavioural change.change. StrategiesStrategies include:include: ¾ planningplanning timetime toto engageengage inin nonnon--drugdrug relatedrelated behaviourbehaviour ¾ avoidingavoiding oror leavingleaving aa drugdrug--useuse situation.situation. 14 ImportantImportant conceptsconcepts inin CBTCBT (2)(2) CBTCBT attemptsattempts toto helphelp clients:clients: Follow a planned schedule of low-risk activities Recognise drug use (high-risk) situations and avoid these situations Cope more effectively with a range of problems and problematic behaviours associated with using 15 ImportantImportant conceptsconcepts inin CBTCBT (3)(3) AsAs CBTCBT treatmenttreatment continuescontinues intointo laterlater phasesphases ofof recovery,recovery, moremore emphasisemphasis isis givengiven toto thethe ““cognitivecognitive”” partpart ofof CBT.CBT. ThisThis includes:includes: Teaching clients knowledge about addiction Teaching clients about conditioning, triggers, and craving Teaching clients cognitive skills (“thought stopping” and “urge surfing”) Focusing on relapse prevention 16 FoundationsFoundations ofof CBTCBT TheThe learninglearning andand conditioningconditioning principlesprinciples involvedinvolved inin CBTCBT are:are: ¾ClassicalClassical conditioningconditioning ¾OperantOperant conditioningconditioning ¾ModellingModelling 17 ClassicalClassical conditioning:conditioning: ConceptsConcepts Conditioned Stimulus (CS) does not produce a physiological response, but once we have strongly associated it with an Unconditioned Stimulus (UCS) (e.g., food) it ends up producing the same physiological response (i.e., salivation). = 18 ClassicalClassical conditioning:conditioning: AddictionAddiction ¾ RepeatedRepeated pairingspairings ofof particularparticular events,events, emotionalemotional states,states, oror cuescues withwith substancesubstance useuse cancan produceproduce cravingcraving forfor thatthat substancesubstance ¾ OverOver time,time, drugdrug oror alcoholalcohol useuse isis pairedpaired withwith cuescues suchsuch asas money,money, paraphernalia,paraphernalia, particularparticular places,places, people,people, timetime ofof day,day, emotionsemotions ¾ Eventually,Eventually, exposureexposure toto cuescues alonealone producesproduces drugdrug oror alcoholalcohol cravingscravings oror urgesurges thatthat areare oftenoften followedfollowed byby substancesubstance abuseabuse 19 ClassicalClassical conditioning:conditioning: ApplicationApplication toto CBTCBT techniquestechniques (1)(1) ¾ UnderstandUnderstand andand identifyidentify ““triggerstriggers”” (conditioned(conditioned cues)cues) ¾ UnderstandUnderstand howhow andand whywhy ““drugdrug cravingcraving”” occursoccurs 20 ClassicalClassical conditioning:conditioning: ApplicationApplication toto CBTCBT techniquestechniques (2)(2) ¾ LearnLearn strategiesstrategies toto avoidavoid exposureexposure toto triggerstriggers ¾ CopeCope withwith cravingcraving toto reducereduce // eliminateeliminate conditionedconditioned cravingcraving overover timetime 21 OperantOperant conditioning:conditioning: AddictionAddiction (1)(1) DrugDrug useuse isis aa behaviourbehaviour thatthat isis reinforcedreinforced byby thethe positivepositive reinforcementreinforcement thatthat occursoccurs fromfrom thethe pharmacologicpharmacologic propertiesproperties ofof thethe drug.drug. 22 OperantOperant conditioning:conditioning: AddictionAddiction (2)(2) OnceOnce aa personperson isis addicted,addicted, drugdrug useuse isis reinforcedreinforced byby thethe negativenegative reinforcementreinforcement ofof removingremoving oror avoidingavoiding painfulpainful withdrawalwithdrawal symptoms.symptoms. 23 OperantOperant conditionsconditions (1)(1) PositivePositive
Recommended publications
  • Empirical Evidence for Definitions of Episode, Remission, Recovery, Relapse and Recurrence in Depression: a Systematic Review

    Empirical Evidence for Definitions of Episode, Remission, Recovery, Relapse and Recurrence in Depression: a Systematic Review

    Epidemiology and Psychiatric Sciences (2019), 28, 544–562. © Cambridge University Press 2018 ORIGINAL ARTICLE doi:10.1017/S2045796018000227 Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review P. L. de Zwart1*, B. F. Jeronimus1,2 and P. de Jonge1,2 1 University of Groningen, University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), Groningen, The Netherlands 2 University of Groningen, Faculty of Behavioural and Social Sciences, Department of Developmental Psychology, Groningen, The Netherlands Aims. For the past quarter of a century, Frank et al.’s (1991) consensus-based definitions of major depressive disorder (MDD) episode, remission, recovery, relapse and recurrence have been the paramount driving forces for consistency in MDD research as well as in clinical practice. This study aims to review the evidence for the empirical validation of Frank et al.’s proposed concept definitions and to discuss evidence-based modifications. Methods. A literature search of Web of Science and PubMed from 1/1/1991 to 08/30/2017 identified all publications which referenced Frank et al.’s request for definition validation. Publications with data relevant for validation were included and checked for referencing other studies providing such data. Results. A total of 56 studies involving 39 315 subjects were included, mainly presenting data to validate the severity and duration thresholds for defining remission and recovery. Most studies indicated that the severity threshold for defining remission should decrease. Additionally, specific duration thresholds to separate remission from recovery did not add any predictive value to the notion that increased remission duration alleviates the risk of reoccurrence of depressive symp- toms.
  • Impact of Disclosure of Relapse for Self-Identified Sexual Addicts

    Impact of Disclosure of Relapse for Self-Identified Sexual Addicts

    Sexual Addiction & Compulsivity, 20:157–170, 2013 Copyright © Taylor & Francis Group, LLC ISSN: 1072-0162 print / 1532-5318 online DOI: 10.1080/10720162.2013.786659 ARTICLES Impact of Disclosure of Relapse for Self-Identified Sexual Addicts M. DEBORAH CORLEY Sante´ Center for Healing, Argyle, Texas SARA E. POLLARD and JOSHUA N. HOOK University of North Texas, Denton, Texas JENNIFER P. SCHNEIDER Tucson, Arizona Disclosure as a process of both recovery and healing within commit- ted relationships is advocated by couple and addiction therapists. The traumatic impact for partners of an initial disclosure or discov- ery of betrayals has been well documented, but less is known about the impact of disclosure for sex addicts. The present study explored the experience of relapse and disclosure among sex addicts. Relapse was a common experience among sex addicts, and the disclosure of relapse had a range of consequences for the addict and the re- lationship. Voluntary disclosure of relapse (rather than the partner discovering relapses independently) was associated with positive relational outcomes. The majority of sexual behaviors engaged in by sexual addicts who are in a committed relationship are considered a violation of trust by their partners (Bird, Butler, & Fife, 2007; Kalichman & Cain, 2004; Young, Griffin-Shelley, Cooper, O’Mara, & Buchanan, 2000). This violation is also considered a betrayal and may be described as a secret sexual, romantic, or emotional involvement that violates the rules of and commitment to an exclusive re- lationship (Glass, 2002; Laaser, 2011; Whisman & Wagers, 2005). The most significant betrayals are those associated with repeated secrets, lies, decep- tions, and broken promises (Corley & Schneider, 2002; Corley, Schneider, Thanks to Dr.
  • Medications to Treat Opioid Use Disorder Research Report

    Medications to Treat Opioid Use Disorder Research Report

    Research Report Revised Junio 2018 Medications to Treat Opioid Use Disorder Research Report Table of Contents Medications to Treat Opioid Use Disorder Research Report Overview How do medications to treat opioid use disorder work? How effective are medications to treat opioid use disorder? What are misconceptions about maintenance treatment? What is the treatment need versus the diversion risk for opioid use disorder treatment? What is the impact of medication for opioid use disorder treatment on HIV/HCV outcomes? How is opioid use disorder treated in the criminal justice system? Is medication to treat opioid use disorder available in the military? What treatment is available for pregnant mothers and their babies? How much does opioid treatment cost? Is naloxone accessible? References Page 1 Medications to Treat Opioid Use Disorder Research Report Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone. Overview An estimated 1.4 million people in the United States had a substance use disorder related to prescription opioids in 2019.1 However, only a fraction of people with prescription opioid use disorders receive tailored treatment (22 percent in 2019).1 Overdose deaths involving prescription opioids more than quadrupled from 1999 through 2016 followed by significant declines reported in both 2018 and 2019.2,3 Besides overdose, consequences of the opioid crisis include a rising incidence of infants born dependent on opioids because their mothers used these substances during pregnancy4,5 and increased spread of infectious diseases, including HIV and hepatitis C (HCV), as was seen in 2015 in southern Indiana.6 Effective prevention and treatment strategies exist for opioid misuse and use disorder but are highly underutilized across the United States.
  • TAP 19: Counselor's Manual for Relapse Prevention with Chemically Dependent Criminal Offenders

    TAP 19: Counselor's Manual for Relapse Prevention with Chemically Dependent Criminal Offenders

    Counselor's Manual for Relapse Prevention With Chemically Dependent Criminal Offenders Technical Assistance Publication (TAP) Series 19 DHHS Publication No. (SMA) 96-3115 Printed 1996 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Substance Abuse and Mental Health Services Administration Rockwall II, 5600 Fishers Lane Rockville, MD 20857 Introduction This publication is intended for use by people who are interested in working with criminal offenders who are chemically dependent (addicted to alcohol and/or drugs). It focuses on chemical dependency and the criminal offender, and will present you with information you may not have been exposed to before. Research tells us that most criminal offenders have alcohol or drug problems. It also tells us that traditional forms of treatment for chemical dependency are not very successful with these offenders. Many of them return to using alcohol or drugs after treatment. When this happens, most of them become repeat offenders. This publication is designed to help you teach criminal offenders how they can stay sober and clean. This publication is designed for the paraprofessional counselor. A paraprofessional counselor is someone who wants to help others, but who has little or no professional counselor training. This publication explains basic counseling information in simple terms. It is also designed to help you work with people who are using the Appendix—Relapse Prevention Workbook for Chemically Dependent Criminal Offenders. It explains the purpose of each exercise in this workbook and tells you how to help the patient use and understand the exercises. This publication is based on information that has had better than average results in treating chemically dependent criminal offenders.
  • Alcohol Use Disorder Relapse Factors a Systematic Review

    Alcohol Use Disorder Relapse Factors a Systematic Review

    Psychiatry Research 278 (2019) 97–115 Contents lists available at ScienceDirect Psychiatry Research journal homepage: www.elsevier.com/locate/psychres Alcohol use disorder relapse factors: A systematic review T ⁎ Wilco Sliedrechta, , Ranne de Waartb, Katie Witkiewitzc, Hendrik G. Roozend a De Hoop GGZ, Provincialeweg 70, 3329 KP Dordrecht, the Netherlands b Mentrum/Arkin, Wisselwerking 46-48, 1112 XR Diemen, the Netherlands c The University of New Mexico (UNM), MSC 03-2220, Univ of New Mexico, Albuquerque, NM 87131, USA d The University of New Mexico (UNM), Center on Alcoholism, Substance Abuse, and Addictions (CASAA), MSC 11 6280, 1 Univ of New Mexico, Albuquerque, NM 87106, USA ARTICLE INFO ABSTRACT Keywords: A relapsing-remitting course is very common in patients with an Alcohol Use Disorder (AUD). Understanding the Remittance determinants associated with alcohol resumption remains a formidable task. This paper examines relapse de- Recurrence terminants based on a systematic review of recent alcohol literature (2000–2019). Relevant databases were Relapse determinants consulted for articles that contained information about specific relapse determinants and reported statistical Dual diagnosis significance of each relapse determinant in predicting relapse. Relapse was broadly defined based on the Biopsychosocial model characterization in the included articles. From the initial identified 4613 papers, a total of 321 articles were Spiritual included. Results encompass multiple relapse determinants, which were ordered according to biopsychosocial and spiritual categories, and presented, using a descriptive methodology. Psychiatric co-morbidity, AUD se- verity, craving, use of other substances, health and social factors were consistently significantly associated with AUD relapse. Conversely, supportive social network factors, self efficacy, and factors related to purpose and meaning in life, were protective against AUD relapse.
  • Understanding Addiction, Helping Clients and Colleagues

    Understanding Addiction, Helping Clients and Colleagues

    ALABAMA LAWYER ASSISTANCE PROGRAM Understanding Addiction, Helping Clients and Colleagues By Jeanne Marie Leslie rugs change the brain–they according to the American Bar change its structure and how it Association, is 15 to 18 percent.3 D works.1 Many of these changes Lawyers rank high in the incidences of are responsible for the behaviors we see depression compared to other professions in individuals addicted to drugs. and a disproportionate number of Neuroscience has made significant lawyers commit suicide;4 in Alabama advances in our ability to identify and there are about a dozen lawyer suicides understand the mechanisms involved in every year. And these are only the ones the addicted brain. These advancements about which we know. Many lawyers, clearly confirm what many in the addic- including some you know, may be strug- tion medicine field have known for some gling with an addiction or mental health time: the obsession and compulsion to problem when help is readily available use drugs in the addicted brain is instinc- through ALAP. tual and paramount to survival.2 Ignorance and stigma have contributed Addiction Facts to the confusion, moral judgments and Dr. Nora D. Volkow, director of the poor understanding of this destructive National Institute of Drug Abuse and often fatal disease. Our courts are (NIDA), explains how the neuro-chemi- overwhelmed by the behaviors, criminal cal mechanisms of drug abuse catalyze and civil, associated with addiction. and accelerate the onset addiction: Therefore, understanding addiction is “Recognizing drug addiction as a chron- essential for lawyers. Lawyers are in ic, relapsing disease characterized by com- unique positions to initiate change, to pulsive drug seeking and use is critical to advocate for medical treatment over tra- being able to identify and help those who ditional sanctions and to refer individuals have it.
  • Predicting Relapse to Alcohol and Drug Abuse Via Quantitative Electroencephalography Lance O

    Predicting Relapse to Alcohol and Drug Abuse Via Quantitative Electroencephalography Lance O

    Predicting Relapse to Alcohol and Drug Abuse via Quantitative Electroencephalography Lance O. Bauer, Ph.D. A sensitive and specific screening test that would identify abstinence and 22 additional subjects with no history of the subset of substance-abusing patients at highest risk for substance dependence. Importantly, in subsequent logistic relapse would constitute an important advance for treatment regression analyses, fast ␤ power was found to be superior to planning. This study examined the relative value of severity of illness, depression level, and childhood conduct quantitative electroencephalography as a rapid, inexpensive, problems in predicting relapse. With fast ␤ power as the sole and noninvasive measure of relapse potential. The subjects predictor, the sensitivity, specificity, and positive and were 107 substance-dependent patients enrolled in negative predictive value parameters for discriminating residential treatment programs. All were unmedicated and outcomes were 0.61, 0.85, 0.75, and 0.74, respectively. free of the complicating effects of major medical and Additional ANCOVAs revealed that the EEG difference neurological disorders. Structured clinical interview data between relapse-prone and abstinence-prone groups was and a 5-minute recording of the resting, eyes-closed related to the interaction of two premorbid factors, viz., electroencephalogram were obtained after patients had childhood Conduct Disorder and paternal alcoholism. The verifiably maintained abstinence for 1–5 months. Patients enhancement of fast ␤ electroencephalographic activity in were then monitored for relapse or successful abstinence by patients who will later relapse most likely originates from a research staff for an ensuing 6-month period. ANCOVAs of premorbid and subtle dysfunction involving frontal brain EEG power spectral density within pre-defined frequency regions.
  • ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update

    ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update

    The ASAM NATIONAL The ASAM National Practice Guideline 2020 Focused Update Guideline 2020 Focused National Practice The ASAM PRACTICE GUIDELINE For the Treatment of Opioid Use Disorder 2020 Focused Update Adopted by the ASAM Board of Directors December 18, 2019. © Copyright 2020. American Society of Addiction Medicine, Inc. All rights reserved. Permission to make digital or hard copies of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for commercial, advertising or promotional purposes, and that copies bear this notice and the full citation on the fi rst page. Republication, systematic reproduction, posting in electronic form on servers, redistribution to lists, or other uses of this material, require prior specifi c written permission or license from the Society. American Society of Addiction Medicine 11400 Rockville Pike, Suite 200 Rockville, MD 20852 Phone: (301) 656-3920 Fax (301) 656-3815 E-mail: [email protected] www.asam.org CLINICAL PRACTICE GUIDELINE The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update 2020 Focused Update Guideline Committee members Kyle Kampman, MD, Chair (alpha order): Daniel Langleben, MD Chinazo Cunningham, MD, MS, FASAM Ben Nordstrom, MD, PhD Mark J. Edlund, MD, PhD David Oslin, MD Marc Fishman, MD, DFASAM George Woody, MD Adam J. Gordon, MD, MPH, FACP, DFASAM Tricia Wright, MD, MS Hendre´e E. Jones, PhD Stephen Wyatt, DO Kyle M. Kampman, MD, FASAM, Chair 2015 ASAM Quality Improvement Council (alpha order): Daniel Langleben, MD John Femino, MD, FASAM Marjorie Meyer, MD Margaret Jarvis, MD, FASAM, Chair Sandra Springer, MD, FASAM Margaret Kotz, DO, FASAM George Woody, MD Sandrine Pirard, MD, MPH, PhD Tricia E.
  • Getting Through Amphetamine Withdrawal – a Guide for People

    Getting Through Amphetamine Withdrawal – a Guide for People

    Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page i GETTING THROUGH AMPHETAMINE WITHDRAWAL A guide for people trying to stop amphetamine use Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page ii GETTING THROUGH AMPHETAMINE WITHDRAWAL CONTENTS About this book x Making the decision to stop using amphetamines x Amphetamine withdrawal x What is withdrawal? x How long will the symptoms last? What kinds of symptoms will I have? x Getting started x Organise a safe environment x Organise support x Structure your day x The role of medication x Getting through withdrawal x Cravings x Sleep x September 1996 Relaxing x Revised May 2004 Mood swings x © Turning Point Alcohol and Drug Centre Inc. Strange thoughts x 54-62 Gertrude Street, Fitzroy VIC 3065 Eating again x T: 03 8413 8413 Aches and pains x F: 03 9416 3420 High-risk situations x Counselling x E: [email protected] It’s all too much x www.turningpoint.org.au Sex and withdrawal x Original edition by Dr Nik Lintzeris, Dr Adrian Dunlop and After withdrawal x David Thornton What next? x Updated (2004) by Dr Adrian Dunlop, Sandra Hocking, Dr Getting back on track if you ‘slip up’ x Nicole Lee and Peter Muhleisen Notes for supporters x Cartoonist: Mal Doreian Useful contact numbers x ISBN 0_958 6979_1_4 1 Amphetamine_wdl_220404.qxd 28/04/2004 12:19 PM Page 2 GETTING THROUGH AMPHETAMINE WITHDRAWAL MAKING THE DECISION TO STOP USING AMPHEATMINES ABOUT THIS BOOK This book is written for people who are thinking about You may find it helpful to make a list of the positives and the or trying to stop using amphetamines, even if just for a negatives about using amphetamines.
  • Amphetamines Help People Struggling with Amphetamine Addiction

    Amphetamines Help People Struggling with Amphetamine Addiction

    Reducing Harm & Finding Help, Continued detox facilities, and addiction treatment programs can help with withdrawal. Amphetamine addiction can be treated in a residential setting (often called “rehab”) or in an outpatient setting (when the patient lives at home, but goes to treatment appointments 1-7 times per week). Effective types of counseling for benzodiazepine addiction include cognitive behavioral therapy, motivational interviewing, and twelve- step facilitation. There are also recovery support groups and online forums that can Amphetamines help people struggling with amphetamine addiction. Narcotics Anonymous, Alcoholics Anonymous, and groups like SMART Recovery or LifeRing are all available to support people with Information about amphetamine addiction. Recovery apps specific to amphetamine addiction can be downloaded to your smart phone that Your Health provide lists of recovery support meetings, reading material, tools like sobriety counters, and more. © 2016 Institute for Research, Education and Training in Addictions Amphetamines – Amphetamines & who inject amphetamines and/or share equipment can develop injection site What Are They? My Health, Continued infections, damage to their veins, Hepatitis B & C, HIV, and blood clots. Amphetamines are a category of drug that decisions. For some people, amphetamine include prescription medications (like intoxication can create or worsen mental Adderall), methamphetamine (often illness symptoms like anxiety, paranoia, and shortened to “meth”), and MDMA (often hallucinations. called “ecstasy” or “Molly”). Although these drugs are not identical, they are all included Unknown drugs: Because some amphetamines in the category of amphetamines. are illegal, they carry additional risks. Users of methamphetamine and MDMA cannot be Amphetamines are stimulants. They can sure of the drug’s contents or dose.
  • Molecular Mechanisms of Addiction

    Molecular Mechanisms of Addiction

    Molecular Mechanisms of Addiction Eric J. Nestler Nash Family Professor The Friedman Brain Institute Medical Model of Addiction • Pathophysiology - To identify changes that drugs produce in a vulnerable brain to cause addiction. • Individual Risk - To identify specific genes and non-genetic factors that determine an individual’s risk for (or resistance to) addiction. - About 50% of the risk for addiction is genetic. Only through an improved understanding of the biology of addiction will it be possible to develop better treatments and eventually cures and preventive measures. Scope of Drug Addiction • 25% of the U.S. population has a diagnosis of drug abuse or addiction. • 50% of U.S. high school graduates have tried an illegal drug; use of alcohol and tobacco is more common. • >$400 billion incurred annually in the U.S. by addiction: - Loss of life and productivity - Medical consequences (e.g., AIDS, lung cancer, cirrhosis) - Crime and law enforcement Diverse Chemical Substances Cause Addiction • Opiates (morphine, heroin, oxycontin, vicodin) • Cocaine • Amphetamine and like drugs (methamphetamine, methylphenidate) • MDMA (ecstasy) • PCP (phencyclidine or angel dust; also ketamine) • Marijuana (cannabinoids) • Tobacco (nicotine) • Alcohol (ethanol) • Sedative/hypnotics (barbiturates, benzodiazepines) Chemical Structures of Some Drugs of Abuse Cocaine Morphine Ethanol Nicotine ∆9-tetrahydrocannabinol Drugs of Abuse Use of % of US population as weekly users 100 25 50 75 0 Definition of Drug Addiction • Loss of control over drug use. • Compulsive drug seeking and drug taking despite horrendous adverse consequences. • Increased risk for relapse despite years of abstinence. Definition of Drug Addiction • Tolerance – reduced drug effect after repeated use. • Sensitization – increased drug effect after repeated use.
  • Relapse Prevention Therapy

    Relapse Prevention Therapy

    Clinical Guidelines for Implementing Relapse Prevention Therapy A Guideline Developed for the Behavioral Health Recovery Management Project December 2002 G. Alan Marlatt, Ph.D., George A. Parks, Ph.D., and Katie Witkiewitz, Ph.C. Addictive Behaviors Research Center Department of Psychology BOX 351525 University of Washington Seattle, WA 98195-1525 G. Alan Marlatt, Ph.D. is Professor of Psychology and director of the Addictive Behaviors Research Center where he conducts training and research on the prevention and treatment of alcohol and other addictive behavior problems in college students and Native American Youth as well as on the effects of Vipassana meditation on relapse and general well-being. He received his Ph.D. in psychology from Indiana University. George A. Parks, Ph.D. is a research coordinator at the Addictive Behaviors Research Center where he conducts research and training on brief interventions to reduce college student harmful drinking and the effects of Vipassana Meditation on relapse and general well-being. He received his Ph.D. in psychology from the University of Washington. Katie Witkiewitz, Ph.C. is a doctoral candidate at the University of Washington and a research assistant at the Addictive Behaviors Research Center where she conducts research on relapse and on the effects of Vipassana Meditation on relapse and general well-being. She received her Ph.C. in psychology from the University of Washington. The Behavioral Health Recovery Management Project is an initiative of Fayette Companies, Peoria, IL Chestnut Health Systems, Bloomington, IL and The University of Chicago Center for Psychiatric Rehabilitation The Project is funded by the Illinois Department of Human Services Office of Alcoholism and Substance Abuse Relapse Prevention Therapy (RPT): An Overview “Quitting smoking is easy.